Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics Combined with Enteral Nutrition in Pancreaticoduodenectomy
NCT06719596Phase 2Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- May 2024
- Primary completion
- Jun 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bifidobacterium bifidum in post-operative infection (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Infectious Complications. Started May 2024; status: recruiting.
02
Drugs
bifidobacterium bifidum
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT06719596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06719596.